Publicacions en què col·labora amb Mónica Olivares Martín (19)

2021

  1. Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2537-2551

  2. Lactobacillus fermentum CECT5716 ameliorates high fat diet-induced obesity in mice through modulation of gut microbiota dysbiosis

    Pharmacological Research, Vol. 167

  3. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation

    Nutrients, Vol. 13, Núm. 8

2018

  1. Bacteria-Carried Iron Oxide Nanoparticles for Treatment of Anemia

    Bioconjugate Chemistry, Vol. 29, Núm. 5, pp. 1785-1791

  2. Lactobacillus fermentum Improves Tacrolimus-Induced Hypertension by Restoring Vascular Redox State and Improving eNOS Coupling

    Molecular Nutrition and Food Research, Vol. 62, Núm. 14

  3. The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade

    Molecular Nutrition and Food Research, Vol. 62, Núm. 19

2017

  1. A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota

    Molecular Nutrition and Food Research, Vol. 61, Núm. 8

  2. Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition

    Molecular Nutrition and Food Research, Vol. 61, Núm. 11

2016

  1. Antihypertensive effects of oleuropein-enriched olive leaf extract in spontaneously hypertensive rats

    Food and Function, Vol. 7, Núm. 1, pp. 584-593

  2. Magnetic study on biodistribution and biodegradation of oral magnetic nanostructures in the rat gastrointestinal tract

    Nanoscale, Vol. 8, Núm. 32, pp. 15041-15047

2015

  1. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats

    Molecular Nutrition and Food Research, Vol. 59, Núm. 11, pp. 2326-2336

  2. The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties

    Food and Function, Vol. 6, Núm. 4, pp. 1176-1184

2014

  1. Intestinal anti-inflammatory activity of the polyphenolic-enriched extract Amanda® in the trinitrobenzenesulphonic acid model of rat colitis

    Journal of Functional Foods, Vol. 11, Núm. C, pp. 449-459

  2. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice

    Clinical Science, Vol. 127, Núm. 1, pp. 33-45

2012

  1. The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine

    European Journal of Nutrition, Vol. 51, Núm. 3, pp. 365-374

2009

  1. Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice

    British Journal of Nutrition, Vol. 101, Núm. 1, pp. 51-58

2007

  1. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis

    British Journal of Nutrition, Vol. 97, Núm. 1, pp. 96-103

2006

  1. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis

    International Journal of Colorectal Disease, Vol. 21, Núm. 8, pp. 737-746

2005

  1. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rats colitis

    World Journal of Gastroenterology, Vol. 11, Núm. 33, pp. 5185-5192